P. Sogani

发表

Flow cytometry in bladder cancer detection and evaluation using acridine orange metachromatic nucleic acid staining of irrigation cytology specimens.

M. Melamed, Z. Darżynkiewicz, F. Traganos, 1980, The Journal of urology.

Flow cytometry of normal and nonneoplastic diseases of the bladder: an estimate of the false positive rate.

M. Melamed, W. Whitmore, P. Sogani, 1982, The Journal of urology.

Detection and follow‐up of carcinoma of the urinary bladder by flow cytometry

M. Melamed, W. Whitmore, P. Sogani, 1982, Cancer.

Solitary vaginal metastasis from unsuspected renal cell carcinoma.

W. Whitmore, P. Sogani, 1979, The Journal of urology.

Long-term effect of intravesical bacillus Calmette-Guerin on flat carcinoma in situ of the bladder.

M. Melamed, W. Whitmore, H. Oettgen, 1986, The Journal of urology.

Multicenter, randomized, double-blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancer.

G. Andriole, W. Fair, P. Sogani, 1992, The Journal of urology.

Flutamide and other antiandrogens in the treatment of advanced prostatic carcinoma.

W. Whitmore, P. Sogani, 1988, Cancer treatment and research.

Carcinoma in a bladder diverticulum: presentation and treatment outcome.

G. Dalbagni, D. Golijanin, P. Sogani, 2003, The Journal of urology.

Enhanced bladder cancer detection with the Lewis X antigen as a marker of neoplastic transformation.

M. Melamed, C. Cordon-Cardo, V. Reuter, 1990, The Journal of urology.

Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers

R. Motzer, G. Bosl, D. Wood, 1992, Cancer.

Adjuvant chemotherapy combination of vinblastine, actinomycin D, bleomycin, and chlorambucil following retroperitoneal lymph node dissection for stage II testis tumor

W. Whitmore, P. Sogani, H. Grabstald, 1981, Cancer.

Clinical stage I testis cancer: long-term outcome of patients on surveillance.

H. Thaler, W. Fair, G. Bosl, 1998, The Journal of urology.

Reoperative retroperitoneal surgery.

J. Sheinfeld, P. Sogani, 2007, The Urologic clinics of North America.

Father-son testicular (teratocarcinoma) malignancy.

W. Whitmore, P. Sogani, F. Klein, 1983, Urology.

Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors

G. Bosl, W. Whitmore, P. Sogani, 1986, Cancer.

Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium.

N. Geller, H. Scher, C. Sternberg, 1985, The Journal of urology.

Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancer.

P. Russo, V. Reuter, W. Fair, 1994, British journal of urology.

Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering Cancer Center experience 1950 to 2001.

J. Sheinfeld, J. Holzbeierlein, P. Sogani, 2003, The Journal of urology.

Distribution of retroperitoneal metastases after chemotherapy in patients with nonseminomatous germ cell tumors.

R. Motzer, W. Fair, G. Bosl, 1992, The Journal of urology.

VAB-6 as initial treatment of patients with advanced seminoma.

G. Bosl, W. Whitmore, P. Sogani, 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The role of pelvic lymphadenectomy and radical cystectomy for lymph node positive bladder cancer. The memorial sloan‐kettering cancer center experience

P. Russo, W. Fair, W. Whitmore, 1994, Cancer.

Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion.

V. Reuter, H. Scher, D. Dershaw, 1988, The Journal of urology.

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

N. Geller, N. Bander, H. Scher, 1989, Cancer.

Neoadjuvant chemotherapy in invasive bladder cancer: the evolving role of surgery.

P. Russo, W. Fair, W. Whitmore, 1990, The Journal of urology.

Methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy and cystectomy for unresectable bladder cancer.

P. Russo, D. Bajorin, W. Fair, 1996, The Journal of urology.

Endocrine and exocrine profiles of men with testicular tumors before orchiectomy.

P. Carroll, W. Fair, R. Chaganti, 1987, The Journal of urology.

Carboplatin, etoposide, and bleomycin for patients with poor‐risk germ cell tumors

N. Geller, R. Motzer, H. Scher, 1990, Cancer.

Fertility status of patients with clinical stage I testis tumors on a surveillance protocol.

P. Carroll, L. Klotz, W. Fair, 1987, The Journal of urology.

The role of ifosfamide plus cisplatin‐based chemotherapy as salvage therapy for patients with refractory germ cell tumors

E. Dmitrovsky, N. Geller, P. Russo, 1990, Cancer.

High‐dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated

P. Russo, R. Motzer, W. Fair, 1992, Cancer.

Does early cystectomy improve the survival of patients with high risk superficial bladder tumors?

P. Sogani, H. Herr, H. Herr, 2001, The Journal of urology.

Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.

M. Melamed, V. Laudone, B. Freedman, 1988, Journal of Clinical Oncology.

Screening of Ambulatory Patients for Prostate Cancer by Transrectal Ultrasonography

P. Sogani, R. Stuart, Daniel G. Miller, 1987 .

Penile cancer: relation of extent of nodal metastasis to survival.

W. Whitmore, P. Sogani, H. Herr, 1987, The Journal of urology.

Orchiectomy alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis.

G. Bosl, W. Whitmore, P. Sogani, 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Estrogen, progesterone, and androgen‐binding sites in renal cell carcinoma. Observations obtained in phase II trial of flutamide

H. Scher, W. Whitmore, P. Sogani, 1984, Cancer.

VAB-6 combination chemotherapy in disseminated cancer of the testis.

W. Whitmore, P. Sogani, H. Herr, 1981, Annals of internal medicine.

Advanced prostatic carcinoma: flutamide therapy after conventional endocrine treatment.

W. Whitmore, P. Sogani, B. Ray, 1975, Urology.

Spermatic cord sarcoma in adults.

W. Whitmore, P. Sogani, H. Grabstald, 1978, The Journal of urology.

Presumptive downstaging from preoperative irradiation for bladder cancer as determined by flow cytometry: preliminary report.

M. Melamed, W. Whitmore, P. Sogani, 1983, International journal of radiation oncology, biology, physics.

Combined chemotherapy and surgery in treatment of advanced germ‐cell tumors

M. Bains, W. Whitmore, P. Sogani, 1981, Cancer.

Retroperitoneal lymphadenectomy for germ cell tumor of testis in association with horseshoe kidney.

W. Whitmore, P. Sogani, 1981, Urology.

Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder.

P. Russo, M. Mazumdar, D. Bajorin, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial.

W. Fair, W. Whitmore, Z. F. Zhang, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inguinal lymph node metastases from germ cell testicular tumors.

W. Whitmore, P. Sogani, F. Klein, 1984, The Journal of urology.

Selection of testicular tumor patients for omission of retroperitoneal lymph node dissection.

W. Fair, W. Whitmore, P. Sogani, 1986, The Journal of urology.

VP‐16–213 and cisplatin in the treatment of patients with refractory germ cell tumors

G. Bosl, W. Whitmore, P. Sogani, 1984, American journal of clinical oncology.

Adjuvant chemotherapy with VAB‐3 of stage II‐B testicular cancer

W. Whitmore, P. Sogani, H. Grabstald, 1981, Cancer.

Adjuvant vinblastine, actinomycin D, bleomycin, cyclophosphamide and cis-platinum chemotherapy regimen with and without maintenance in patients with resected stage IIB testis cancer.

W. Whitmore, P. Sogani, H. Herr, 1982, The Journal of urology.

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

N. Geller, N. Bander, H. Scher, 1988, The Journal of urology.

Surveillance alone in the treatment of clinical stage I nonseminomatous germ cell tumor of the testis (NSGCT).

W. Fair, P. Sogani, 1988, Seminars in urology.

Experience with flutamide in patients with advanced prostatic cancer without prior endocrine therapy

W. Whitmore, P. Sogani, M. Vagaiwala, 1984, Cancer.

Lymphocele after pelvic lymphadenectomy for urologic cancer.

W. Whitmore, P. Sogani, R. Watson, 1981, Urology.

Gleason grading of prostate cancer: a predictor of survival.

W. Whitmore, P. Sogani, P. Lieberman, 1985, Urology.

Intravesical cisplatin for superficial bladder tumors

W. Whitmore, P. Sogani, H. Grabstald, 1982, Cancer.

Preoperative irradiation and cystectomy for bladder cancer

W. Whitmore, P. Sogani, H. Grabstald, 1982, Cancer.

Secondary carcinoma of kidney from parotid gland tumor.

P. Sogani, M. Horowitz, 1993, Urology.

Association of primary germ cell tumor of the testis and renal cell carcinoma.

P. Sogani, H. Herr, B. Davis, 1993, The Journal of urology.

Sarcomas of the kidney.

W. Whitmore, P. Sogani, S. Hajdu, 1984, The Journal of urology.

Renal cell carcinoma extending into inferior vena cava.

M. Bains, W. Whitmore, P. Sogani, 1983, The Journal of urology.

The treated natural history of high risk superficial bladder cancer: 15-year outcome.

W. Fair, Michael Cookson, Z. F. Zhang, 1997, The Journal of urology.

Positive urinary cytology following a complete response to intravesical bacillus Calmette-Guerin therapy: pattern of recurrence.

P. Russo, W. Fair, J. Sheinfeld, 1994, The Journal of urology.

Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma.

M. Kattan, P. Russo, B. Bochner, 2004, The Journal of urology.

Malignant melanoma of the penis and male urethra.

A. Diokno, P. Sogani, H. Grossman, 1984, The Journal of urology.

Update in Staging Systems

W. Whitmore, P. Sogani, 1987 .

M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium.

H. Scher, C. Sternberg, W. Fair, 1988, Progress in clinical and biological research.

Experience with flutamide in previously untreated patients with advanced prostatic cancer.

W. Whitmore, P. Sogani, 1979, The Journal of urology.

Inferior pubic rami resection with en bloc radical excision for invasive proximal urethral carcinoma

W. Whitmore, P. Sogani, F. Klein, 1983 .

Inferior pubic rami resection with en bloc radical excision for invasive proximal urethral carcinoma.

W. Whitmore, P. Sogani, F. Klein, 1983, Cancer.

Panniculectomy in conjunction with radical cystectomy in the obese patient.

W. Whitmore, P. Sogani, F. Klein, 1983, Surgery, gynecology & obstetrics.

Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors.

V. Reuter, H. Scher, C. Sternberg, 1988, The Journal of urology.

Intravascular capillary hemangioma presenting as a solid renal mass.

E. Genega, P. Sogani, G. W. Hull, 1999, The Journal of urology.

Case Reports INTMVASCULAR CAPILLARY HEMANGIOMA PRESENTING AS A SOLID RENAL MASS

E. Genega, P. Sogani, G. W. Hull, 1999 .

Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.

Paul Russo, P. Russo, B. Bochner, 2004, The Journal of urology.

Comparisons of nomograms and urologists' predictions in prostate cancer.

M. Kattan, P. Scardino, M. Gonen, 2002, Seminars in urologic oncology.

Phase II trial of intravesical gemcitabine in bacille Calmette-Guérin-refractory transitional cell carcinoma of the bladder.

P. Russo, L. Ben-Porat, B. Bochner, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study.

C. Begg, P. Russo, V. Reuter, 1997, British journal of urology.

Use of neoadjuvant androgen deprivation therapy in clinically localized prostate cancer.

V. Reuter, W. Fair, A. Aprikian, 1993, Clinical and investigative medicine. Medecine clinique et experimentale.

The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center results.

C. Begg, P. Russo, V. Reuter, 1997, Urology.

Ureteropyeloscopy: the diagnostic and therapeutic approach to upper tract urothelial tumors

W. Fair, W. Whitmore, P. Sogani, 1985, World Journal of Urology.

Characterization of bladder papilloma by two-parameter DNA-RNA flow cytometry.

M. Melamed, Z. Darżynkiewicz, W. Whitmore, 1982, Cancer Research.

274: Phase II Trial of Intra Vesical Gemcitabine in BCG-Refractory Transitional Cell Carcinoma of the Bladder

P. Russo, M. Mazumdar, B. Bochner, 2004 .

Paternity in men with stage I testis tumors on surveillance.

P. Sogani, H. Herr, N. Bar-Chama, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of advanced prostatic cancer.

W. Fair, P. Sogani, 1987, The Urologic clinics of North America.

A Randomized Trial of Etoposide + Cisplatin Versus Vinblastine + Bleomycin + Cisplatin + Cyclophosphamide + Dactinomycin in Patients with Good-Prognosis Germ Cell Tumors

N. Geller, J. Auman, H. Scher, 1989 .

Evolution of the management of stage I nonseminomatous germ-cell tumors of the testis.

P. Sogani, 1991, The Urologic clinics of North America.

125iodine reimplantation for locally progressive prostatic carcinoma.

K. Wallner, Z. Fuks, W. Whitmore, 1990, The Journal of urology.

An evaluation of automated flow cytometry (FCM) in detection of carcinoma in situ of the urinary bladder

M. Melamed, W. Whitmore, P. Sogani, 1982, Cancer.

Clinical Downstaging After Neo-Adjuvant M-VAC for Transitional Cell Carcinoma of the Urothelium

H. Scher, C. Sternberg, W. Fair, 1987 .

Evaluation and treatment of cryptorchidism: AUA guideline.

Andrew C. Peterson, P. Dahm, R. Breau, 2014, The Journal of urology.

Experience with interstitial implantation of iodine 125 in the treatment of prostatic carcinoma.

W. Whitmore, P. Sogani, B. Hilaris, 1980, Scandinavian journal of urology and nephrology. Supplementum.

Carcinoma of the prostate: treatment with pelvic lymphadenectomy and iodine-125 implants.

J. Montie, W. Whitmore, P. Sogani, 1979, Clinical bulletin.

Neoadjuvant chemotherapy for bladder cancer: the MSKCC experience.

V. Reuter, H. Scher, W. Fair, 1990, Seminars in urology.

Evaluation and treatment of cryptorchidism: AUA Guideline

R. Breau, H. Salem, S. Docimo, 2019 .

Summary of intermittent endocrine therapy for advanced prostate cancer (by Laurence H. Klotz, MD, Harry W. Herr, MD, Michael J. Morse, MD, and Willet F. Whitmore, Jr, MD). 1986.

L. Klotz, P. Sogani, N. Block, 1997, Seminars in Urologic Oncology.

The role of neoadjuvant hormonal manipulation in localized prostatic cancer

W. Fair, W. Whitmore, V. Reuter, 1993, Cancer.

FoIlo wing Retroperitoneal Lymph Node Dissection for Stage I 1 Testis Tumor

P. Sogani, H. Grabstald, E. Cvitkovic, 2006 .